Kenalog Intra-Articular / Intramuscular

Triamcinolone Acetonide, the active ingredient in Kenalog Intra‑Articular / Intramuscular, is a glucocorticoid presented as an injectable suspension for intra‑articular and intramuscular use. It treats inflammatory joint conditions such as osteoarthritis, rheumatoid arthritis, bursitis and tendinitis in adult patients.

GNH USA supplies Kenalog Intra‑Articular / Intramuscular as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kenalog (triamcinolone acetonide) is a glucocorticoid that reduces inflammation in musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and swelling. - Rheumatoid arthritis: alleviates synovial inflammation and improves joint function. - Bursitis: decreases bursae swelling and associated discomfort. - Tendinitis: mitigates tendon sheath inflammation and pain. - Other inflammatory joint conditions: provides symptomatic relief and improves mobility.

Adverse reactions may occur following intra‑articular or intramuscular administration of triamcinolone acetonide.

Common Side Effects: - Injection‑site pain or tenderness. - Transient hyperglycemia, especially in diabetic patients. - Mild elevation of blood pressure. - Local bruising or discoloration.

Serious or Rare Side Effects: - Adrenal suppression with prolonged use. - Severe infections due to immunosuppression. - Osteonecrosis of the jaw or other bones. - Anaphylactic or severe allergic reactions.

Prior to administration, clinicians should evaluate patient‑specific risk factors and follow safe handling practices.

- Assess infection risk: screen for active infections before injection. - Monitor blood glucose: patients with diabetes should have glucose levels checked. - Evaluate bone health: prolonged therapy may affect bone density. - Use caution in hypertension: monitor blood pressure regularly. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Triamcinolone acetonide may interact with several drug classes; awareness of these interactions helps mitigate risk.

Major Interactions (Avoid): - Live vaccines: may diminish vaccine efficacy. - Anticoagulants: increased risk of bleeding. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic steroid exposure.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened gastrointestinal ulcer risk. - Diuretics: potential potassium loss and electrolyte imbalance. - Antidiabetic agents: possible alteration of glucose control. - ACE inhibitors: may exacerbate fluid retention.